Rapamycin Protects From Type-I Peritoneal Membrane Failure Inhibiting the Angiogenesis, Lymphangiogenesis, and Endo-Mt

BioMed Research International - United States
doi 10.1155/2015/989560
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Exendin-4 Protects Pancreatic Beta Cells From the Cytotoxic Effect of Rapamycin by Inhibiting JNK and P38 Phosphorylation

Hormone and Metabolic Research
BiochemistryEndocrinologyClinical BiochemistryMedicineMetabolismDiabetes
2010English

Notch in Pathological Angiogenesis and Lymphangiogenesis

2012English

Integrins in Tumor Angiogenesis and Lymphangiogenesis

Methods in Molecular Biology
GeneticsMolecular Biology
2011English

Hepatocyte Growth Factor Signalizes Peritoneal Membrane Failure in Peritoneal Dialysis

BMC Nephrology
Nephrology
2014English

Rapamycin Suppresses Angiogenesis and Lymphangiogenesis in Melanoma by Downregulating VEGF-A/VEGFR-2 and VEGF-C/VEGFR-3 Expression

OncoTargets and Therapy
OncologyPharmacology
2019English

Semaphorin Signaling in Angiogenesis, Lymphangiogenesis and Cancer

Cell Research
Cell BiologyMolecular Biology
2011English

Interactions Between Lymphangiogenesis and Angiogenesis During Dermal Wound Healing

Journal of the American College of Surgeons
Surgery
2017English

Gene Variants in Angiogenesis and Lymphangiogenesis and Cutaneous Melanoma Progression

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2013English

Endostatin's Emerging Roles in Angiogenesis, Lymphangiogenesis, Disease, and Clinical Applications

Biochimica et Biophysica Acta - General Subjects
BiochemistryMolecular BiologyBiophysics
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy